Odyssey Therapeutics (NASDAQ:ODTX) Upgraded to “Hold” at Wall Street Zen

Wall Street Zen upgraded shares of Odyssey Therapeutics (NASDAQ:ODTX) to a hold rating in a research report report published on Saturday.

Odyssey Therapeutics Stock Up 1.7%

Shares of NASDAQ:ODTX opened at $17.62 on Friday. Odyssey Therapeutics has a fifty-two week low of $15.35 and a fifty-two week high of $20.30.

Insider Buying and Selling at Odyssey Therapeutics

In other Odyssey Therapeutics news, Director Dimension Capital Ii, L.P. acquired 1,111,111 shares of the stock in a transaction on Friday, May 8th. The stock was acquired at an average price of $18.00 per share, for a total transaction of $19,999,998.00. Following the completion of the transaction, the director directly owned 3,333,516 shares of the company’s stock, valued at $60,003,288. This trade represents a 50.00% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, major shareholder Tpg Gp A, Llc acquired 1,388,889 shares of the stock in a transaction on Monday, May 11th. The shares were acquired at an average price of $18.00 per share, with a total value of $25,000,002.00. Following the transaction, the insider directly owned 3,690,146 shares of the company’s stock, valued at $66,422,628. The trade was a 60.35% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Insiders have purchased 4,183,777 shares of company stock valued at $75,319,986 over the last ninety days.